logo

For the Inventor, By the Inventor

Osaka, Japan

Mikio Konishi

This inventor holds 6 USPTO granted patents. Top assignees: Ono Pharmaceutical Co., Ltd., Ono Pharmaceuticals Co., Ltd.. Active years: 2002-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikio Konishi. Retrieved from https://idiyas.com/inventor/mikio-konishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 16.7

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Mishima-gun, JP (2004)
  • Osaka, JP (2002 - 2011)

Company Filing History:

goldMedal5 out of 575 
 
Ono Pharmaceutical Co., Ltd.
 patents
silverMedal1 out of 22 
 
Ono Pharmaceuticals Co., Ltd.
 patents

Years Active: 2002-2011

Loading Chart...
6 patents (USPTO):Explore Patents
1. 8008451 - Antibodies to TNF (tumor necrosis factor) receptor family members (2011-08-30),
2. 7705140 - DNAs encoding TNF receptor family members (2010-04-27),
3. 7396908 - OAF065alpha and OAF065beta polypeptides (2008-07-08),
4. 6770644 - Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient (2004-08-03),
5. 6555555 - Fused thiophone derivatives and drugs containing the same as the active ingredient (2003-04-29),
6. 6420391 - Fused thiophone derivatives and drugs containing the same as the active ingredient (2002-07-16),

Title: Mikio Konishi: Innovator in Biopharmaceuticals

Introduction

Mikio Konishi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibodies and polypeptides. With a total of 6 patents, his work has had a substantial impact on medical research and treatment options.

Latest Patents

Konishi's latest patents include innovative developments related to antibodies targeting tumor necrosis factor (TNF) receptor family members. His patents detail the polypeptide produced from human stromal cell lines, the processes for preparing these polypeptides, and the DNA encoding them. Additionally, he has developed vectors carrying the DNA, host cells transformed by these vectors, and pharmaceutical compositions containing the polypeptides or antibodies.

Career Highlights

Throughout his career, Mikio Konishi has worked with notable companies such as Ono Pharmaceutical Co., Ltd. and Ono Pharmaceuticals Co., Ltd. His expertise in biopharmaceuticals has positioned him as a key figure in the industry, contributing to advancements in therapeutic solutions.

Collaborations

Konishi has collaborated with esteemed colleagues, including Mitoshi Konno and Tadamitsu Kishimoto. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Mikio Konishi's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…